StandardX is a UK-headquartered deep-tech company building the world's first scalable isotope refinery: a proprietary compact accelerator system that manufactures the full portfolio of rare isotopes at commercial scale on a standard industrial footprint, replacing today's fragmented, isotope-specific production infrastructure. Founded in 2025 by nuclear engineers Richard Pearson and Ross Allen, the company starts with isotopes for cancer diagnosis and treatment, including targeted alpha therapies, and plans to extend the same platform to tritium fuel for fusion energy under signed agreements with fusion developers. It aims to supply its first isotopes to a medical research partner in 2027 and reach industrial-scale production from 2029.
1
Round
1
Industry
3
Tags
Sep 23, 2026
Latest raise
Funding activity · 1 round
Sep 23, 2026
GBP 10M
Seed
Led by Vsquared Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
